Dena Michelle Godwin Hernandez is a neurogeneticist. She is head of the genomic technologies group in the laboratory of neurogenetics at the National Institute on Aging.[1]
Hernandez completed a Ph.D. at the UCL Queen Square Institute of Neurology in 2016. Her dissertation was titled Genetic variation and DNA methylation in the context of neurological disease. Hernandez's doctoral advisors were Andrew Singleton and John Hardy.[2]